Tourette Syndrome Clinical Trial
Official title:
Timing of Voluntary Movement in Patients With Tourette Syndrome and Chronic Tic Disorder Using EEG and Surface EMG
Verified date | January 12, 2009 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will examine how the brain controls movement in people with Tourette syndrome and
chronic tic disorder to determine if the timing of movement is important in whether someone
feels "in control" of their movements. Although movements in tic disorders are often
characterized as "involuntary," some patients claim that these movements are made
voluntarily, or they are unable to decide if they are voluntary or involuntary. Previous
experiments have shown that when people are asked to look at a clock and report the time they
first decide to make a movement they report times later than the first brain waves associated
with movement appear. When they are asked to report the time they first initiate the
movement, they report times before the muscles actually begin to move. This study may help
determine how the sense of willing and initiating an action is altered in patients with
Tourette syndrome and chronic tic disorder, and how people may feel more or less "in control"
of their movements.
Normal volunteers and patients with Tourette syndrome or chronic tic disorder between 18 and
65 years of age may be eligible for this study. Control subjects must not have any
neurological or psychological disorders, and patients with Tourette syndrome of chronic tic
disorder must not have any other neurological disorders. Patients with attention deficit
hyperactivity disorder (ADHD) may not enroll in this study.
All participants will have a medical history, physical examination, and a test to determine
their level of attention. Patients will be interviewed about their symptoms and complete
psychiatric rating scales. In addition, all participants will undergo the following
procedures:
Electric shock
Participants look at a clock on a computer screen, the hands of which revolves quickly. While
looking at the clock, each participant will be given small, non-painful electric shocks and
asked, according to the clock, to say when they received the shocks. The shocks are repeated
40 times.
Arm movement
Participants are asked to lift their arms off a table repeatedly, at random times, while they
look at the computer clock. This exercise is repeated 80 times. Of these 80, participants are
asked 10 times consecutively to say the time they first had the desire to move their arm, and
then 10 consecutively the time they first felt that they were moving their arm.
Electroencephalography (EEG) and Electromyography (EMG)
Participants undergo EEG and EMG durin...
Status | Completed |
Enrollment | 42 |
Est. completion date | January 12, 2009 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
- INCLUSION CRITERIA: Tic Patients: Patients will be men or women, ages 18-65, with a DSM-IV-TR diagnosis of TS or CTD. Patients will be screened in the NINDS Movement Disorders Outpatient Clinic, and will have neurological and physical examinations. They will be asked to abstain from alcohol and any medications for 24 hours before the study. All subjects participating in the studies will have a valid Clinical Center Medical Record Number. Normal Volunteers: Twenty-six normal controls will be included; controls will be screened in the NINDS Movement Disorders Outpatient Clinic, and will have neurological and physical examinations. They will be asked to abstain from alcohol and any medications for 24 hours before the study. All subjects participating in the studies will have a valid Clinical Center Medical Record Number. EXCLUSION CRITERIA: Patients younger than 18 years old or older than 65 years old will be excluded from the study. Tic Patients: Patients with neurological disorders other than TS or CTD Patients with Attention deficit hyperactivity disorder (ADHD) Patients who are not able to abstain from alcohol or medication affecting the central nervous system for 24 hours before the study Patients not capable of giving an informed consent Normal Subjects: Patients with neurological disorders or ADHD Patients who are not able to abstain from alcohol or medication affecting the central nervous system for 24 hours before the study Patients not capable of giving an informed consent |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Berardelli A, Currà A, Fabbrini G, Gilio F, Manfredi M. Pathophysiology of tics and Tourette syndrome. J Neurol. 2003 Jul;250(7):781-7. Review. — View Citation
Goetz CG, Leurgans S, Chmura TA. Home alone: methods to maximize tic expression for objective videotape assessments in Gilles de la Tourette syndrome. Mov Disord. 2001 Jul;16(4):693-7. — View Citation
Gomes G. Problems in the timing of conscious experience. Conscious Cogn. 2002 Jun;11(2):191-97. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04851678 -
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
|
||
Completed |
NCT02605902 -
Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders
|
N/A | |
Completed |
NCT04007913 -
Incorporating teleCBIT Into a Hospital-Based Tic Program
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Completed |
NCT02216474 -
Brain Stimulation in Movement Disorders
|
N/A | |
Completed |
NCT02256475 -
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT01329198 -
Brain Stimulation for the Treatment of Tourette Syndrome
|
N/A | |
Terminated |
NCT00952601 -
Pilot Study of the Modified Atkins Diet for Tourette Syndrome
|
Phase 1 | |
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00206323 -
A Randomized, Placebo-controlled, Tourette Syndrome Study.
|
Phase 3 | |
Completed |
NCT00004376 -
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
|
Phase 3 | |
Completed |
NCT04498364 -
Extinction Learning in Adults With Tourette Syndrome
|
N/A | |
Completed |
NCT00755339 -
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
|
||
Completed |
NCT03325010 -
Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Completed |
NCT01702077 -
Neurofeedback for Tourette Syndrome
|
N/A | |
Completed |
NCT01719523 -
Open-Trial of EPI-743 for Adults With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT00231985 -
Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder
|
Phase 2 | |
Completed |
NCT00206336 -
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
|
Phase 3 | |
Terminated |
NCT03732534 -
Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
|
Phase 2 |